SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-005649
Filing Date
2024-02-09
Accepted
2024-02-09 15:47:35
Documents
16
Period of Report
2024-02-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40405
2 ex99-1.htm EX-99.1 17386
3 ex99-1_001.jpg GRAPHIC 19628
  Complete submission text file 0001493152-24-005649.txt   260428

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aim-20240208.xsd EX-101.SCH 3015
5 XBRL LABEL FILE aim-20240208_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE aim-20240208_pre.xml EX-101.PRE 22360
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3500
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 24614519
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)